Evolution of the Average Target: Ipsen

Data source: Ipsen(IPN)

Evolution of the Target Price: Ipsen

Data source: Ipsen(IPN)

Changes in Analyst Recommendations: Ipsen

Data source: Ipsen(IPN)
4ce1181d7c6157c83ed6fa.tcq-odo1o7xlTClfpsBjHwz0X0NRGH44S1L9DmQkbf0.3vuP8bQY7f4dHUNr5fU8c0eZLRAechEMCCK_dgdeBKSHvfKS73KO7Sk0EQ~d55cd27d51f19a6833dccecc51b66855
Sep. 18 AlphaValue/Baader Europe Ups Price Target, Forecasts for Ipsen on 'Solid' H1 Performance MT
Sep. 17 Ipsen: Incorporating solid H1 operational performance + guidance upgrade Alphavalue
Sep. 17 Ipsen extends its pullback despite AlphaValue Zonebourse
Aug. 20 Cancer vaccines finally garner the spotlight Alphavalue
Aug. 17 Kepler Cheuvreux Boosts Ipsen PT, Maintains Hold Rating MT
Aug. 03 Jefferies Downgrades Ipsen to Underperform, Boosts PT MT
Jul. 30 Ipsen: Another quarterly beat; 2026 guidance upgraded Alphavalue
Jul. 14 Where would AI lead Pharma in the long run? Alphavalue
Jul. 07 AlphaValue/Baader Europe Cuts Ipsen Price Target Amid Future Patent Expiries, Mid-term Risks MT
Jul. 06 Ipsen: Reassessing mid-term risks Alphavalue
Jul. 01 AlphaValue/Baader Europe Downgrades Ipsen to Add, Lifts PT MT
Jul. 01 Oddo BHF still neutral on Ipsen after a new acquisition Zonebourse
Jun. 30 Ipsen Extends Its Rally, Backed by Oddo BHF Zonebourse
Jun. 05 HC Wainwright Starts Ipsen Coverage with Buy Rating MT
May. 28 Ipsen Price Target, Estimates Up as AlphaValue/Baader Europe Notes Upcoming Data Readouts, Product Mix MT
May. 27 Ipsen: Beneficiary of favourable product mix and imminent readouts Alphavalue
Apr. 24 Profit-taking hits Ipsen despite UBS price target hike Zonebourse
Apr. 23 Ipsen: Opened the year with encouraging traction Alphavalue
Apr. 14 Deutsche Bank raises price target on Ipsen Zonebourse
Mar. 16 BNP Paribas Upgrades Ipsen to Neutral, Boosts PT MT
Mar. 10 CIC Corporate & Institutional Banking Upgrades Ipsen to Buy, Boosts PT MT
Feb. 13 Ipsen Remains in the Green with UBS Support Zonebourse
Feb. 12 Ipsen: Markets applaud strong finish to 2025 and better-than-expected 2026 outlook Alphavalue
Jan. 14 Ipsen, Top Gainer on the SBF 120 and SRD at Wednesday, January 14, 2026 Close Zonebourse
Jan. 14 Ipsen and EMS-Chemie Shine on the Stock Market, Vistry and Pearson Struggle Zonebourse

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+14.96%
+2.93%
+5.55%
+5.2%
+9.33%
+26.46%
+0.53%
+10.16%
+5.35%
Average +8.94%
Weighted average by Cap. +9.46%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
155.90EUR
Average target price
166.07EUR
Spread / Average Target
+6.52%
High Price Target
235.00EUR
Spread / Highest target
+50.74%
Low Price Target
130.00EUR
Spread / Lowest Target
-16.61%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
AA
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!